Ftse Mib
34.799,27
-0,83%
DAX
20.132,85
-0,44%
S&P 500
5.836,22
0,16%
NASDAQ
19.088,10
-0,38%
Bitcoin
95.351,68
0,89%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ CG Oncology Inc (CGON) CG Oncology Inc (CGON) Notizie

CG Oncology Inc

CGON
28,68
-1,52 (-5,03%)
14 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/1/202522:15EDGAR2Form 8-K - Current report
18/12/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:05GLOBECG Oncology Announces Closing of Public Offering and Full..
13/12/202422:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
13/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
13/12/202402:19GLOBECG Oncology Announces Pricing of Public Offering
11/12/202422:09EDGAR2Form S-1/A - General form for registration of securities..
11/12/202412:17GLOBECG Oncology Announces Proposed Public Offering
06/12/202414:00GLOBESUO-CTC and CG Oncology Announce the First Annual Non-Muscle..
05/12/202413:52EDGAR2Form 8-K - Current report
05/12/202413:00GLOBEGroundbreaking Cretostimogene Grenadenorepvec Monotherapy..
02/12/202414:00GLOBECG Oncology to Host Conference Call and Webcast on BOND-003..
20/11/202414:00GLOBECG Oncology to Present Results on Cretostimogene..
12/11/202414:11EDGAR2Form 8-K - Current report
12/11/202414:00GLOBECG Oncology Reports Third Quarter 2024 Financial Results and..
11/11/202414:00GLOBECG Oncology Announces Nature Medicine Publication of Phase..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/10/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202414:00GLOBECG Oncology to Participate in the Morgan Stanley 22nd Annual..
30/8/202402:26EDGAR2Form 144 - Report of proposed sale of securities
08/8/202414:23GLOBECG Oncology Reports Second Quarter 2024 Financial Results..
08/8/202412:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202412:19EDGAR2Form 8-K - Current report
18/6/202414:00GLOBECG Oncology Initiates Expanded Access Program for..
06/6/202418:14GLOBECG Oncology Announces Nature Medicine Publication of Final..
24/5/202414:15EDGAR2Form 8-K - Current report
24/5/202414:00GLOBECG Oncology to Present Positive Final Results from Phase 2..
09/5/202414:10EDGAR2Form 8-K - Current report
09/5/202414:00GLOBECG Oncology Reports First Quarter 2024 Financial Results and..
09/5/202412:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/5/202417:23GLOBECretostimogene Monotherapy Demonstrated 75.2% Complete..
26/4/202414:00GLOBECG Oncology to Host Virtual Investor Event on Friday, May 3,..
24/4/202416:00GLOBECG Oncology to Unveil Encouraging Results on Cretostimogene..
28/3/202413:00GLOBECG Oncology to Present Results on Cretostimogene at the AUA..
27/2/202414:00GLOBECG Oncology Announces First Patient Dosed in PIVOT-006 Phase..
30/1/202413:00BWCG Oncology Announces Closing of Initial Public Offering and..
Apertura: 29,66 Min: 27,86 Max: 29,96
Chiusura: 30,20

La tua Cronologia

NASDAQ
CGON
CG Oncology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network